Single-Cell RNA-seq Analysis Has Matured—Why Bioinformatics Expertise Matters More Than Ever

Over the past decade, single-cell RNA sequencing (scRNA-seq) has transformed biological research. What was once a cutting-edge technology is now a standard tool for studying cellular heterogeneity, disease mechanisms and therapeutic responses. As the field has matured, so has the bioinformatics required to analyse these datasets, and with it the gap between simply running a pipeline and producing answers a research programme can be built on.

Routine scRNA-seq Analysis Is More Accessible Than Ever

Routine scRNA-seq analysis is now more accessible than ever. Community-supported frameworks such as Seurat and Scanpy provide well-established workflows for quality control, normalisation, clustering, visualisation and differential expression analysis, the core steps that turn raw sequencing reads into annotated cell populations and lists of genes that differ between them. Much like bulk RNA-seq, straightforward datasets with good experimental design can often be analysed using standardised pipelines.

Where AI Helps and Where It Stops

Artificial intelligence is also allowing scientists with limited coding experience to work more independently. AI assistants can help researchers understand analysis workflows, generate code and troubleshoot routine programming issues. However, AI cannot replace scientific judgement when experimental design, statistical modelling or biological interpretation become more complex.

Why Modern Single-Cell Study Designs Are Harder to Analyse

Today’s studies often involve multiple patient cohorts, longitudinal sampling, batch effects (systematic technical differences between samples processed at different times, sites or on different instruments), and integration of scRNA-seq with other single-cell and spatial omics technologies such as single-cell ATAC-seq, CITE-seq and spatial transcriptomics. These challenges require far more than a standard analysis workflow. Selecting appropriate methods, accounting for technical variation and interpreting results in their biological context all demand specialist expertise. Furthermore, as the scale of single-cell studies has expanded, the resulting data sets require increased storage capacity, improved data management strategies, and advanced computational infrastructure to enable efficient processing and analysis.

Bioinformatics Value Starts Before Sequencing

Experienced bioinformaticians can add value at each stage of a scRNA-seq experiment, even long before sequencing begins. Decisions around study design, sample numbers, controls, and sequencing depth can have a major impact on the quality and interpretability of the final dataset. Early bioinformatics input helps maximise the value of every experiment while reducing the risk of costly downstream issues.

In practice, this is often decisive. A power calculation at the design stage can show that a certain number of samples per arm will not resolve a rare cell population of interest, avoiding a study that cannot answer its own question. Randomising samples across processing batches costs nothing at the bench but can be the difference between a clean integration and a confounded one. And agreeing analysis endpoints before sequencing keeps the final dataset aligned with the decision it was generated to support, whether that is a target call, a biomarker hypothesis or a regulatory submission.

How Fios Genomics Approaches Single-Cell Analysis

At Fios Genomics, we see bioinformatics as more than data processing. We partner with our clients from experimental design through advanced downstream analyses, including multi-omics integration, trajectory inference (reconstructing how cells transition between states over time), cell–cell communication analysis (mapping the signalling between cell populations) and biological interpretation, to ensure complex studies deliver robust, publication-quality and decision-ready insights. Our work spans platforms from 10x Genomics to Drop-seq and Smart-seq2, and study scales from focused immune profiling to large-scale datasets. For example, distinguishing normal from malignant epithelial cells in non-small cell lung cancer. To see how we report single-cell findings, request our example scRNA-seq report on immune cell subsets in healthy donor PBMCs.

As single-cell technologies continue to evolve, expert bioinformatics remains essential, not because routine analyses have become more difficult, but because the scientific questions have become more sophisticated.

Planning a single-cell study? Talk to our team about your experimental design before you sequence, early input is the best point at which to protect the value of the dataset.

Author: Katerina Boufea, Principal Bioinformatician, Fios Genomics